Article
Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during…
medRxiv · 2022 · Fu-Qing Jiang
Key facts
| Title | Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration |
|---|---|
| First author | Fu-Qing Jiang |
| Journal | medRxiv |
| Published | Mar 1, 2022 |
| DOI | 10.1101/2022.02.27.482166 |
| Devices mentioned | 202111, K800552, K810863, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529 and 14 more |
| Product codes mentioned | DBM, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JLX, KKX and 3 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1